AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

RDY · NYSE · Drug Manufacturers - Specialty & Generic

Dr. Reddy's Laboratories (ADR) (RDY)

Produces generics, branded medicines, biosimilars, active ingredients, and consumer health products.

$12.57

After hours0.00 (0.00%)

At close$12.57(+1.37%)

India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
ReutersSep 17
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
PRNewsWireSep 17
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
GlobeNewsWireSep 15
RDY SHAREHOLDER ALERT: Dr. Reddy's Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
GuruFocusAug 13
RDY SHAREHOLDER ALERT: Dr. Reddy's Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Business WireAug 13
Arrowstreet Capital Limited Partnership Buys Shares of 102,643 Dr. Reddy’s Laboratories Ltd $RDY
Defense WorldAug 6
Dr. Reddy's Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States
Business WireAug 4
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
GuruFocusJul 31
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
PRNewsWireJul 31
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Dr. Reddy's Laboratories (RDY)
GlobeNewsWireJul 29
RDY Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Dr. Reddy's Laboratories (RDY)
Business WireJul 28
Dr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY)
PRNewsWireJul 24
U.S. pharma tariffs 'can't be absorbed' and drug prices will increase, says Dr Reddy's CEO
CNBC International TVJul 24
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
CNBCJul 23
Dr Reddy's Laboratories Ltd (RDY) Shares Surge 3.7% -- What GF Score of 83 Tells Investors
GuruFocusJul 23
Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down
Zacks Investment ResearchJul 23
Dr. Reddy's Laboratories Limited (RDY) Q1 2027 Earnings Call Transcript
Seeking AlphaJul 22
Dr. Reddy's Laboratories Q1 Earnings Call Highlights
MarketBeatJul 22
Indian drugmaker Dr Reddy's posts quarterly profit slump
ReutersJul 22
Dr. Reddy’s Laboratories Ltd $RDY Holdings Lifted by Bessemer Group Inc.
Defense WorldJul 19